Mike Westby

Novel indazole non-nucleoside reverse transcriptase inhibitors using molecular hybridization based on crystallographic overlays.

Catherine Burt, Chris Phillips, T. Knöchel, 2009, Journal of medicinal chemistry.

Small Molecules Targeting Hepatitis C Virus-Encoded NS5A Cause Subcellular Redistribution of Their Target: Insights into Compound Modes of Action

David Pryde, Lyn H. Jones, Chris Pickford, 2011, Journal of Virology.

Characterizing the Diverse Mutational Pathways Associated with R5-Tropic Maraviroc Resistance: HIV-1 That Uses the Drug-Bound CCR5 Coreceptor

Simon A. A. Travers, David L. Robertson, Xiaowei Jiang, 2015, Journal of Virology.

CCR5 Antagonists: Host-Targeted Antivirals for the Treatment of HIV Infection

M. Westby, E. van der Ryst, Mike Westby, 2005, Antiviral chemistry & chemotherapy.

Emergence of CXCR4-Using Human Immunodeficiency Virus Type 1 (HIV-1) Variants in a Minority of HIV-1-Infected Patients following Treatment with the CCR5 Antagonist Maraviroc Is from a Pretreatment CXCR4-Using Virus Reservoir

Mike Youle, M. Youle, J. Whitcomb, 2006, Journal of Virology.

A Pharmacokinetic-Pharmacodynamic Model to Optimize the Phase IIa Development Program of Maraviroc

B. Poland, M. Westby, E. van der Ryst, 2006, Journal of acquired immune deficiency syndromes.

Subgroup analyses of maraviroc in previously treated R5 HIV-1 infection.

Bernard Hirschel, Adriano Lazzarin, B. Hirschel, 2008, The New England journal of medicine.